#BettingonGaming #Stocks #Podcast Episode 10 - News from (NASDAQ: $ALGN) (NASDAQ: $MSGM) (TSX: $EGLX.TO) (OTCQB: $ENGMF)

#BettingonGaming #Stocks #Podcast Episode 10 - News from (NASDAQ: $ALGN) (NASDAQ: $MSGM) (TSX: $EGLX.TO) (OTCQB:  $ENGMF)

 

Point Roberts WA, Delta BC, February 26, 2021 Investorideas.com, a global investor news source releases today’s edition of the  Betting on Gaming Stocks Podcast , featuring gaming, casino and  e-sports stock news from TSX, TSXV, CSE, ASX, NASDAQ, NYSE  companies plus interviews with CEO's and leading experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/022621-Gaming.mp3

 

Read this in full at https://www.investorideas.com/news/2021/gaming-podcasts/02261ALGN-MSGM-EGLX-ENGMF.asp

 

Listen to Investor Ideas podcasts on Spotify

 

Transcript

In today’s episode of Investorideas “Betting on Gaming Stocks” Podcast we look at a few public and private company announcements.

 

Align Technology, Inc. (Nasdaq: ALGN), makers of the Invisalign clear aligner system, announced a partnership with the six-time NBA Champion Golden State Warriors, making the Invisalign brand the Official Smile Partner of the Golden State Warriors. As part of the agreement, the Invisalign brand is also the Official Smile Partner of the Santa Cruz Warriors, Golden State’s G League affiliate team and of the Golden Guardians, its esports affiliate.

The sponsorship includes an omni-channel activation across TV, digital media, and social and a jersey partnership with the Golden Guardians and the Santa Cruz Warriors.

 

“We always look for the right opportunities to meet fans where they live, work and play, and to connect with them around the things they’re passionate about – whether that is a winning smile or a winning team,” said Raj Pudipeddi, Align Technology chief innovation, product, and marketing officer. “We are excited for this three point play to reach fans of the Golden State Warriors, Santa Cruz Warriors, and Golden Guardians. We look forward to sharing smile-making moments with Warriors fans, and to seeing the Invisalign brand name featured in fun social media activations with teens and adults, across the Golden State, Santa Cruz and Golden Guardian teams.”

 

“We are thrilled to partner with the Invisalign brand to enhance our digital fan experience across all of our franchise properties,” said Warriors Senior Vice President of Partnerships, Mike Kitts. “This collaboration will allow for deeper engagement and connection with all Warriors properties and fans around the world. Dub Nation is all about joy in buckets – this partnership captures the joy and smiles of Warriors basketball and the must-see, exciting content through this multi-property collaboration.”

 

As part of the sponsorship, Align has selected Junior Achievement of Northern California as a nonprofit organization whose logo will also be featured on player jerseys. Junior Achievement’s purpose is to inspire and prepare young people for success, which mirrors Align’s philanthropic philosophy to support organizations that improve smiles and support and educate teens.

 

Motorsport Games Inc. (NASDAQ: MSGM), a leading racing game developer, publisher and esports ecosystem provider of official motorsport racing series throughout the world, today announced the launch of Traxion.gg, a brand-new content platform dedicated to the world of virtual motorsport and racing games.

 

Traxion is the home for all things virtual racing, bringing users the latest news, reviews, updates, opinions and insights from the racing game world. The new site will cover the complete spectrum of racing games, ranging from hardcore simulation titles to arcade classics and everything in-between. The platform will give users access to the most recognized and respected names in sim racing with a variety of written, video and streamed content in both long and short forms, as well as podcasts and more.

 

Originally codenamed APEX, the addition of Traxion to Motorsports Games adds a third vertical to the company’s product portfolio that will sit alongside the development of racing games and the creation, production and broadcast of genre defining esports.

 

“Motorsport Games has a mission to revolutionize the world of virtual racing and the launch of Traxion is the next step in that process. Traxion will provide the online racing community with the go-to destination for the very best racing game and esports content,” said Dmitry Kozko, CEO of Motorsport Games. “Our parent company, Motorsport Network, possesses unrivalled experience in building communities built upon best-in-class editorial content. We will continue that legacy with Traxion, as this is just the start for the platform, which will continue to grow and evolve in the coming months to become the true online home of racing games.”

 

“Traxion is an extremely exciting platform that sits perfectly at the intersection of motorsport and video games. We will be covering every kind of game in the racing genre and esports space, no matter the age, platform or discipline. We believe that we can make Traxion a highly engaged, positive community that evangelizes about games and online racing in all of its forms,” added Thomas Harrison-Lord, who has joined Traxion as editor.

 

Enthusiast Gaming Holdings Inc., (TSX: EGLX) (OTCQB: ENGMF), the largest gaming platform in North America, reaching over 300 million monthly video game and esports fans worldwide, announced the upcoming launch of a new premium online publication dedicated to the growing needs of today’s esports fan. Combining content elements from the Company’s two existing esports coverage outlets, Upcomer and Daily Esports, Enthusiast Gaming will relaunch one unified esports publication later this spring.

The new publication, which will operate as Upcomer, will leverage its existing user and prediction engine, to create one of the most complete esports fan engagement experiences. Today’s esports fans crave more than just scores, stats and editorial content. They want a more complete offering - one destination for all of their content and data needs. Upcomer is where the past, present and future of esports will meet.

Upcomer will be led by former ESPN esports editor Sean Morrison. Enthusiast Gaming is planning a full reveal of its award-winning staff roster and management later this spring.

The publication’s suite of content will include:

●      News and editorial

●      Longform features

●      In-depth interviews

●      Video documentary series

●      App, social media and website activations

●      Comprehensive scores, stats and more

●      Match prediction and schedules

●      Fantasy leagues

●      Betting odds

●      Tournament brackets and standings

●      Follow teams and players from major esports leagues

●      Community discussions

According to a recent study from consumer research firm, Interpret, 52% of esports fans said they are likely to engage in some form of betting on esports tournaments. As an esports betting companion, Upcomer will also become a vital data and content tool to enrich the betting experience.

“For the past few months, Enthusiast Gaming has hired some of the best and brightest talent from across the globe, including journalists, editors, content and video producers, to spearhead a deeper dive into the world of esports content. With a fun, conversational approach, Upcomer, will surprise, excite and inspire fans with unique features, perspectives and personalities,” commented Sean Morrison, Editor-in-Chief of Upcomer.

OverActive Media recently unveiled its plans to build a new 7,000-seater esports and entertainment venue at Exhibition Place in Toronto, Canada.

The new venue, which is slated for completion in 2025, will serve as the home for OverActive Media’s Call of Duty League (CDL) and Overwatch League (OWL) franchises, Toronto Ultra and Toronto Defiant. Expected to cost nearly US$500 million, it will also include a ‘theatre-style entertainment venue and hotel complex’.

The project will be the first new sports or entertainment venue built in Toronto since BMO Field, home of Major League Soccer’s (MLS) Toronto FC, in 2007.

Reports of the planned venue, which will be one of the largest esports-specific arenas in North America, first emerged last July.

The facility plans to host more than 200 events a year, driven primarily by premium music and entertainment bookings. As well as a full slate of esports events, it will also look to attract major city-wide conventions, corporate events, product launches and awards shows.

‘The bang for buck is so much greater’: Blast’s Robbie Douek evaluates esports’ 2021 prospects

OverActive Media added that the wider vision for the arena is to help elevate Toronto and Canada as a destination of choice for the global esports and gaming industry.

The facility was conceived by design firm Populous, which previously worked on the Tottenham Hotspur Stadium, the 2012 London Olympic Stadium and the Arizona Cardinals’ State Farm Stadium.

“Today is another important step in the evolution of OverActive Media. We are building a world leading, 21st century sports media and entertainment company and this best-in-class performance venue will be the chosen home for a new generation of fans that think differently about their entertainment choices and experiences,” said Chris Overholt, OverActive's president and chief executive.

“It has always been our intention to develop a venue and hosting strategy and to build a facility that could not only serve as an iconic home for our two franchises, but ultimately emerge as a global hub for major international esport events. We are already in active discussions to attract some of the biggest esport events in the world. This venue will redefine Toronto’s event hosting opportunities in every way.

“Our vision on this project from day one has been to combine a premium concert and live events programme with world leading technology and best in class hospitality. We will create an unparalleled experience for our fans while being a low net cost producer to our entertainment partners and artists. A landmark experience and venue for a world class city that defines a new future.”

The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

 

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

 

Research gaming stocks at Investorideas.com with our gaming, casino  e-sports  stocks directory at Investorideas.com

https://www.investorideas.com/GIS/Stock_List.asp

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash  and others.

 

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp and https://www.investorideas.com/About/News/Clientspecifics.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

GamingIndustryStocks.com - investing ideas in gaming stocks, gambling and casino stocks, game publishers and developers stocks

Like Gaming Stocks? View our Gaming Stocks Directory 

Get News Alerts on Gaming Stocks

Buy a gaming or casino guest post on Investorideas.com

 

Investor Ideas #Potcasts 536, #Cannabis News and #Stocks on the Move; (CSE: $DELC.C) (OTCQB: $DELCF), (TSX: $CWEB.TO) (TSXV: $N.V)

 

Investor Ideas #Potcasts 536, #Cannabis News and #Stocks on the Move; (CSE: $DELC.C) (OTCQB: $DELCF), (TSX: $CWEB.TO) (TSXV: $N.V)

 

Delta, Kelowna, BC, February 26, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/022621-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/02261DELC-DELCF-CWEB-N.asp

 

Hear the investor ideas potcast on Spotify

 

Hear Investor ideas cannabis potcast on iTunes  

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we look at a few public company announcements.

 

Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF), a psychedelic wellness-focused company, announced that it has executed a definitive share purchase agreement to acquire all of the issued and outstanding shares in the capital of Complex Biotech Discovery Ventures ("CBDV"), a licensed psilocybin and cannabis research laboratory focused on extraction, analytical testing, and chemical process development. Founded by award-winning chemist, Dr. Markus Roggen, and UBC Professor, Glenn Sammis, CBDV supports the psychedelic industry with high precision chemical analytics and metabolomic identification. Following the Transaction, CBDV expects to change its name to "DELIC Labs".

 

Transaction Highlights

●       The acquisition of CBDV will further establish DELIC as a diversified psychedelics organization: The addition of CBDV will allow DELIC to add scientific-based research and analytics to its product offerings. CBDV recently received its Section 56 Exemption granted by Health Canada, enabling CBDV to focus on research and intellectual property development with psilocybin.

●       Building an Intellectual Property ("IP") portfolio: CBDV plans to use its analytical tools for psychedelic mushroom compounds that advance clinical ‎and end-user testing. Development of psilocybin analogs that could be used in future medical ‎treatments.

●       Enhanced exposure of CBDV to drive growth: DELIC expects to drive customers to CBDV through its media platform, allowing CBDV to expand its current customer base and potential product offerings.

●       History of profitability: CBDV has a history of profitability, with a focus on extraction optimization, analytical testing, and chemical process development to advance the cannabis and psilocybin industry. Current and past customers are well-established global enterprises who require the cutting-edge cannabis and soon, psilocybin research, which CBDV provides services to.

●       Management expertise. Dr. Roggen, who will remain as an employee of CBDV following closing of the Transaction, brings a wealth of knowledge and industry experience to DELIC, in a critically important and evolving space.

 

Matt Stang, Founder and CEO of DELIC, commented, "Joining forces with CBDV is a foundational transaction for DELIC. Science and research is the backbone of the psychedelic renaissance and adding the talent, know-how and expertise of CBDV will bear fruit both now and in the years to come. The fact that the company has a world-class team, history of profitability, more than 50 blue chip clients, and is on track for significant growth, makes this a compelling acquisition for DELIC and one that makes it a pillar of the Company. Going forward, with the discussions we currently have in place with the many entrepreneurs worldwide within the DELIC ecosystem, we see an opportunity to potentially commercialize this science in the near term."

 

CBDV is one of a handful of licensed research psilocybin labs in Canada and has an aggressive plan to build out a suite of novel compounds and delivery methods for the industry. The company is also a leading cannabis analytical and research company boasting clients that include some of the largest brands in the world. CBDV intends to apply for its dealer's license, to eventually commercialize its psilocybin research and associated IP.

Dr. Roggen, CEO of CBDV, stated "This is a very exciting moment for us at CBDV. Partnering with DELIC was an easy choice. The combination will allow us to use their platform to share our findings with the psychedelic and medical community while also gaining new clients on the cannabis front. It's a great opportunity to work in tandem with the DELIC team to help these new age treatments become accessible for all."

 

Matt Stang continues, "The DELIC ecosystem will benefit greatly from the IP that will come out of CBDV. As new jurisdictions start to decriminalize and legalize psilocybin, we feel we will have the IP that everyone will want. On top of that, our roots in cannabis are deep and we feel we can direct significant revenue in our network towards CBDV's cannabis business." 

 

Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF), the market leader in hemp CBD wellness products, today announced a long-term scientific collaboration between McLean Hospital, a Harvard Medical School affiliate, and the Company.  Funding and product support are provided by the CW Labs division of Charlotte's Web Inc.

 

Two distinct clinical trials will be overseen by lead researcher/investigator Dr. Staci A. Gruber, Ph. D, Associate Professor of Psychiatry at Harvard Medical School and Director of the MIND program at McLean Hospital in Belmont, Mass.  These two studies will investigate the efficacy of a custom-formulated, hemp-derived high-CBD product. Clinical trial results are to be published in 2022. Dr. Gruber is also conducting a number of other studies, including a longitudinal observational study of Veterans who use a Charlotte's Web product.

 

Dr. Gruber's Marijuana Investigations for Neuroscientific Discovery (MIND) Program, established in 2014, is the first of its kind, and is dedicated to studying the long-term impact of cannabis and cannabinoids for medical and adult use which utilizes various clinical and cognitive tools as well as multimodal neuroimaging techniques.

 

"We are honored to be working with Dr. Gruber, Harvard Medical School and McLean Hospital on these important clinical trials," said Tim Orr, President of Charlotte's Web's CW Labs divison. "Charlotte's Web remains dedicated to supporting third-party research on hemp CBD investigated by some of the country's top scientists."

 

Namaste Technologies Inc. (TSXV: N) (OTC: NXTTF) a marketplace platform for cannabis and wellness products, announced that www.CannMart.com is live in the USA offering Americans hemp derived CBD and smoking accessories. Namaste is excited to be leveraging its VendorLink technology in collaboration initially with DankStop and PeakBirch Logic, Inc., and looks forward to adding more partners to the platform.

 

The announcement of this expansion in the USA underscores Namaste’s intention to increase its total addressable market and exploration into other verticals and geographies as regulation evolves and other adjacent complementary market opportunities present themselves.

 

“With ever stronger signals that the regulatory landscape in the USA is evolving, our entry into the jurisdiction through the sale of hemp derived CBD and accessories will position us strategically to begin capturing new market share and build a first mover advantage if and when cannabis becomes legalized federally,” said Meni Morim, CEO of Namaste. “This development also further validates our investment in technology, as the expansion will be facilitated via our marketplace technology. We look forward to building on this positive momentum as we continue to execute our strategy to position Namaste as a leading global cannabis and wellness company.”

 

“Our goal will be to aggressively expand our footprint into the USA as we scale up our marketplace platform,” said Chad Agate, CTO and VP of Marketplace at Namaste. “We are not growing or exporting products from Canada into the USA, we are simply carving out our role as the facilitators using CannMart.com and our VendorLink platform. American and other companies that wish to sell legal products in the USA can now use our innovative platform to conduct business similarly to Amazon. We look forward to adding more partners selling their innovative products throughout the USA.”

 

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) today announced its 2020 fourth quarter and full-year business results.

“Our fourth quarter 2020 results are the summation of the hard work and perseverance the Company has put into this past year despite the challenges of 2020. As we look to 2021, I’m incredibly excited about the teams we have supporting our brands and the breakthrough research and development ("R&D"), innovation and exciting marketing campaigns Cronos Group plans to execute on. We are poised to build upon the growth we experienced in 2020 as we continue to push cannabinoid innovation and differentiated product offerings under our portfolio of brands,” said Kurt Schmidt, President and CEO of Cronos Group. “My goals this year will be to focus on building a winning team by fostering a collaborative, performance-driven culture; continue to focus on creating disruptive technology and innovation; grow and develop our brands and strengthen our ability to compete through R&D, strategic global infrastructure and engaging in the legislative process in key markets.”

Fourth Quarter 2020

●      Net revenue of $17.0 million in Q4 2020 increased by $9.7 million from Q4 2019. The increase year-over-year was primarily driven by continued growth in the adult-use market in Canada, sales in the Israeli medical market and growth in our U.S. segment. Partially offset by non-recurring wholesale revenue in the Canadian market in Q4 2019 and strategic price reductions on various adult-use cannabis products in Canada in Q4 2020.

●      Gross loss of $14.9 million in Q4 2020 decreased by $5.2 million from Q4 2019. The decrease in losses year-over-year was primarily driven by a decline in inventory write-downs and increased gross profit in the U.S. segment. Offset by third party purchased flower associated with adult-use products in Canada and a decline in wholesale sales in Q4 2020 versus Q4 2019.

●      The Company incurred an inventory write-down in Q4 2020 of $15.0 million on dried cannabis and cannabis extracts, primarily driven by cannabis product price compression in the Canadian market. The Company may incur further inventory write-downs due to pricing pressures in the marketplace.

●      Adjusted EBITDA loss of $53.1 million in Q4 2020 increased by $1.5 million from Q4 2019. The increase in losses year-over-year was primarily driven by an increase in general and administrative expenses and an increase in R&D spending.

●      Capital expenditures of $11.0 million in Q4 2020 increased by $10.2 million from Q4 2019. The increase year-over-year was primarily driven by spending at the Company's Peace Naturals campus, Cronos Fermentation, our Israeli facility, and our new ERP system.

Full-Year 2020

●      Net revenue of $46.7 million in Full-Year 2020 increased by $23.0 million from Full-Year 2019. The increase year-over-year was primarily driven by continued growth in the adult-use market in Canada, growth in our U.S. segment, which included a full-year of the Redwood business as opposed to 117 days in Full-Year 2019, and sales in the Israeli medical market. Partially offset by non-recurring wholesale revenue in the Canadian market in Full-Year 2019 and strategic price reductions on various adult-use cannabis products in Canada in Full-Year 2020.

●      Gross loss of $25.8 million in Full-Year 2020 increased by $8.2 million from Full-Year 2019. The increase in losses year-over-year was primarily driven by third party purchased flower associated with adult-use products in Canada and a decline in wholesale sales in Full-Year 2020 versus Full-Year 2019. Partially offset by increased gross profit in the U.S. segment due to a full year of results from the Redwood business and a decrease in inventory write-downs in the ROW segment.

●      The Company incurred an inventory write-down in Full-Year 2020 of $26.1 million, on dried cannabis and cannabis extracts, primarily driven by cannabis product price compression in the Canadian market. The Company may incur further inventory write-downs due to pricing pressures in the marketplace.

●      Adjusted EBITDA loss of $147.3 million in Full-Year 2020 increased by $48.9 million from Full-Year 2019. The increase in losses year-over-year was primarily driven by an increase in gross loss, increased general and administrative expenses, higher sales and marketing costs related to brand development and R&D spending.

●      Capital expenditures of $35.4 million in Full-Year 2020 decreased by $3.6 million from Full-Year 2019. The decrease year-over-year was primarily driven by a reduction in spending at the Company's Peace Naturals campus and Cronos Israel. Partially offset by an increase in spending at Cronos Fermentation.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

 

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 

 

Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory